Pure Global
NCT06344819

An Acupuncture Study for People At High Risk for Sepsis

Acupuncture to Improve Outcomes in Sepsis Patient: The ACTIONS Trial
Memorial Sloan Kettering Cancer Center·Phase 2·ClinicalTrials.gov·procedureRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Sepsis
Drug/Device/Intervention
Acupuncture
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Memorial Sloan Kettering Cancer Center
Location
New York, United States of America
Timeline & enrollment
Phase
Phase 2
Start date
Mar 20, 2024
End date
Mar 20, 2028
Enrollment
78 participants
Primary outcome

Number of participants recruited compared to the number of participants who complete study treatment.

Summary

Researchers think acupuncture may improve outcomes for participants with sepsis, based on
 laboratory studies and previous studies in people with sepsis. The purpose of this study to
 see whether real acupuncture can improve outcomes for participants with sepsis when compared
 to sham acupuncture. Sham acupuncture is performed the same way as real acupuncture but will
 use different needles and target different sites or places on the body than real acupuncture.

ICD-10 classifications
Other sepsisSepsis, unspecifiedOther specified sepsisCandidal sepsisPuerperal sepsis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06344819
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06344819 through Pure Global AI's free database. This Phase 2 trial is sponsored by Memorial Sloan Kettering Cancer Center and is currently Recruiting. The study focuses on Sepsis. Target enrollment is 78 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.